Diagnosis and treatment of latent tuberculosis (TB) infection (LTBI) is essential for the elimination of TB. Preventive therapy could be limited to those with recent TB contact. QuantiFERON-TB Gold Plus (QFT-Plus), a new Interferon-γ release assay, includes a new antigen tube (TB2), which elicits CD4+ and CD8+ T-cell responses. The aim of the study was to evaluate CD8+ T-cell response as a marker of recent TB infection. We retrospectively studied 1165 patients who were screened for LTBI.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Serviço
Contact Serviço, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack